Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRCP | P42785 | 1/20 | 0.39 |
| ▸ | GNAO1 | P09471 | 11/20 | 0.38 |
| ▸ | GNAI3 | P08754 | 10/20 | 0.38 |
| ▸ | GNAI1 | P63096 | 10/20 | 0.38 |
| ▸ | CCR2 | P41597 | 3/20 | 0.36 |
| ▸ | CCR1 | P32246 | 1/20 | 0.35 |
| ▸ | CCR5 | P51681 | 1/20 | 0.35 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24449512 | 0.91 | PRCP (0.40) | PRCPGNAO1GNAI3GNAI1CCR2 | |
| SCHEMBL21743439 | 0.91 | PRCP (0.40) | PRCPGNAO1GNAI3GNAI1CCR2 | |
| SCHEMBL21191744 | 0.91 | PRCP (0.40) | PRCPGNAO1GNAI3GNAI1CCR2 | |
| SCHEMBL18823467 | 0.91 | PRCP (0.40) | PRCPGNAO1GNAI3GNAI1CCR2 | |
| SCHEMBL22020922 | 0.91 | PRCP (0.40) | PRCPGNAO1GNAI3GNAI1CCR2 | |
| SCHEMBL19627720 | 0.89 | PRCP (0.39) | PRCPGNAO1GNAI3GNAI1CCR2 | |
| SCHEMBL22024596 | 0.87 | CCR2 (0.38) | PRCPGNAO1GNAI3GNAI1CCR2 | |
| SCHEMBL21191705 | 0.85 | CCR2 (0.37) | PRCPGNAO1GNAI3GNAI1CCR2 | |
| SCHEMBL22024192 | 0.83 | CCR2 (0.39) | PRCPGNAO1GNAI3GNAI1CCR2 | |
| SCHEMBL19627516 | 0.82 | PRCP (0.35) | PRCPGNAO1GNAI3GNAI1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11718638-B2 | Compounds, compositions and methods for synthesis | WAVE LIFE SCIENCES LTD. (SG) | 2023-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11718638-B2 | Compounds, compositions and methods for synthesis | ALKBH1, DUT, RNGTT | PRCP 3982/4885GNAO1 1001/4885GNAI3 976/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.